Start-Ups
The Digest: June 2025
In this month's news, a slew of 510(k) clearances, Boston Scientific pulls TAVR devices, Medtronic spins out diabetes division, and more.
Welcome to MyStrategist, the digital home for MedTech Strategist.
MedTech Strategist, the global medical device industry's most trusted resource, will help you stay ahead of the opportunities and obstacles that are impacting your corporate strategy. We invite you to explore our coverage. Think Strategically. Subscribe Today
Browse Latest IssueStart a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Business Strategies
Controversy Over Chronic Low Back Pain: Will Industry Step Up?
A controversial set of papers in The British Medical Journal challenging the efficacy of common interventions for chronic low back pain reflects glaring gaps in treatment of a condition that affects millions, but industry has yet to commit substantial resources to addressing the underlying problems.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
Investors & Dealmaking
MedTech Capital Matters June 2025
We present selected private financings for May and June, including Alpheus Medical's over-subscribed $50 million Series B round to support its randomized controlled clinical trial on its novel sonodynamic therapy for glioblastoma. Plus a snapshot of our featured cancer impact investor, ACS BrightEdge.